BSAC Standing Committee on Susceptibility Testing
The BSAC Susceptibility Testing Standing Committee was established in 1981; it developed one of the first standardised susceptibility testing disc diffusion methods in 2001. In recent years, the committee has played an essential role in EUCAST, moving to harmonise breakpoints and standardise susceptibility testing throughout Europe & now the World.
The committee now aims to:
- Support UK laboratories through the transition from BSAC to EUCAST disc diffusion methods
- Support further development of EUCAST susceptibility testing methods
- Improve quality of susceptibility testing through educational User Group Days & Residential Workshops
Membership:
| Dr Robin Howe (Chair) | Consultant Microbiologist, University Hospital of Wales, Cardiff |
| Dr. Mandy Wootton (Secretary) | Lead Scientist, SACU, University Hospital of Wales, Cardiff |
| Prof. Alasdair MacGowan | Consultant Microbiologist, Southmead Hospital, Bristol |
| Prof. David Livermore | Prof. of Medical Microbiology, University of East Anglia, Norwich |
| Dr. Nicholas Brown | Consultant Microbiologist, Addenbrookes Hospital, Cambridge |
| Dr. Trevor Winstanley | Clinical Scientist, Northern General Hospital, Sheffield |
| Dr. Derek Brown | EUCAST Scientific Secretary |
| Mr. Christopher Teale | Animal & Plant Health Agency, Shrewsbury |
| Prof. Gunnar Kahlmeter | EUCAST Steering Committee member, Vӓxjӧ, Sweden |
| Dr. Karen Bowker | Clinical Scientist, Southmead Hospital, Bristol |
| Dr. Gerry Glynn | Medical Microbiologist, Altnagelvin Hospital, N. Ireland |
| Dr. Fiona MacKenzie | Manager, Scottish Microbiology & Virology Network, Aberdeen |
| Ms. Phillipa Burns | Sn. BMS, Public Health England, Manchester |





